On December 13, we had the privilege of taking part in a special professional event.
At the Anaphylactogenic Molecules Conference, a new collaboration was launched between physicians, laboratory professionals, healthcare providers, and civil patient partner, the Association for People with Anaphylactic Allergies.
The event had a clear dual focus.
🔹 To introduce ImmunoCAP molecular allergy diagnostics, already available nationwide, to the professional community
🔹 To actively support public health insurance reimbursement for molecular (component-resolved) allergy diagnostics — a life-saving tool for many patients that is currently accessible mainly through private healthcare
We were honored by the participation of Professor Dr. Rudolf Valenta (Medical University of Vienna), whose pioneering work has played a decisive role in the development of molecular allergy diagnostics.
Further presentations were delivered by Felix Gastager (HVD Life Sciences), as well as leading Hungarian experts in allergology and laboratory medicine:
Dr. Adrienne Nagy, Dr. Lajos Attila Réthy, Dr. Ádám Balogh, and Eszter Nagy.
We sincerely thank all speakers for their excellent contributions and the high-quality professional discussion. We are confident that the collaboration initiated at this event will translate into meaningful progress for patients living with allergies and anaphylaxis.
